Trending...
- Grammy award-winning Cuban-Canadian artist Alex Cuba releases his 11th studio album, "Indole"
- $73.6M Pipeline, $10M Crypto Play & Legal Firepower: Why Investors Are Watching Cycurion (N A S D A Q: CYCU) Like a Hawk
- California: Crime is down in San Francisco, key law enforcement partnerships yield successful results
HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a new modality for treating all stages of cancer, today announced that eight clinical abstracts evaluating the use of its novel technology were accepted for presentation during the virtual American Society for Radiation Oncology (ASTRO) 2020 Annual Meeting, Oct. 24-28.
"We are thrilled to have eight abstracts from leading academic clinicians highlighting our technology," said Sean Shirvani, M.D., senior vice president of Clinical and Medical Affairs at RefleXion. "The presentations will share new data on the potential of BgRT for targeting tumors in diverse anatomic locations and from varied histologies, including non-small cell lung, prostate and pancreatic cancers. The investigations also explore the exciting opportunity of leveraging PET information as a future biomarker with BgRT.
More on The Californer
"Through our clinical partnerships, we continue to produce comprehensive, evidence-based research that builds on the strong foundation of previously published studies," continued Shirvani. "We believe the RefleXion X1 can form the backbone of any radiotherapy clinic, as it delivers IMRT/SBRT/SRS and unlocks opportunities for procedural growth with BgRT in local and metastatic disease."
The following presentations taking place during ASTRO 2020 evaluate RefleXion's novel technology:
Sunday, Oct 25, 2:15 PM. Poster Session 02, Poster Hall:
Monday, Oct 26, 12:20 PM Physics 06 – Imaging and Response Assessment:
Tuesday, Oct 27:
About RefleXion Medical
More on The Californer
RefleXion is a privately-held therapeutic oncology company developing the first biology-guided radiotherapy (BgRT) machine, with the potential to move beyond single tumor therapy to one day treat multiple metastatic tumors throughout the body in the same treatment session. Currently, the RefleXion machine is cleared for the delivery of stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT). The company is also developing BgRT, which incorporates positron-emission tomography (PET) data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with sub-second latency.
*The RefleXion X1 BgRT capability requires 510(k) clearance; this feature is not available for sale.
"We are thrilled to have eight abstracts from leading academic clinicians highlighting our technology," said Sean Shirvani, M.D., senior vice president of Clinical and Medical Affairs at RefleXion. "The presentations will share new data on the potential of BgRT for targeting tumors in diverse anatomic locations and from varied histologies, including non-small cell lung, prostate and pancreatic cancers. The investigations also explore the exciting opportunity of leveraging PET information as a future biomarker with BgRT.
More on The Californer
- California: TOMORROW: Governor Newsom to discuss the economic advancement and growth of the state
- California: Governor Newsom to Trump: We're suing immediately if you send troops into San Francisco
- Long Beach: City to Host Neighborhood Halloween Carnival at Silverado Park
- Altadena Mountain Rescue Team Recognized with 2025 ReadyCommunities Partnership National Service Award For Determination and Resilience
- Long Beach to Host Urban Forest Plan Kickoff Meeting
"Through our clinical partnerships, we continue to produce comprehensive, evidence-based research that builds on the strong foundation of previously published studies," continued Shirvani. "We believe the RefleXion X1 can form the backbone of any radiotherapy clinic, as it delivers IMRT/SBRT/SRS and unlocks opportunities for procedural growth with BgRT in local and metastatic disease."
The following presentations taking place during ASTRO 2020 evaluate RefleXion's novel technology:
Sunday, Oct 25, 2:15 PM. Poster Session 02, Poster Hall:
- 2686 "Simultaneous Integrated Boost of Lung Tumors in the Stereotactic Ablative Setting using BgRT Tracked Delivery"
- 2831 "Use of a Detailed Process Map for Clinical Workflow of a New Biology-guided Radiotherapy (BgRT) Machine"
- 2768 "Feasibility of Biology-Guided Radiotherapy for Pancreatic Tumors: An Assessment of Normalized Target SUV"
Monday, Oct 26, 12:20 PM Physics 06 – Imaging and Response Assessment:
- SS 21 – "Increased 18F-FDG Metabolic Activity During Lung SBRT Predicts Risk of Disease Progression: Results from a Prospective Study of Serial Inter-Fraction PET/CTs"
Tuesday, Oct 27:
- 3:15 PM QP-19 – Physics – Motion Management "Feasibility of Biology-guided Radiotherapy (BgRT) Targeting FDG Avid Liver Metastases"
- 2:00 PM 2268 PV 06 Poster "FDG-PET Metrics in Advanced Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis"
- 2:00 PM 2258 PV 06 Poster "Prognostic Value of FDG-PET Metrics for Advanced NSCLC Patients Treated with First-line Immunotherapy"
About RefleXion Medical
More on The Californer
- Alander Lee Pulliam Jr. Declares His Bold Rise in Politics: A Mission Rooted in Service and Justice
- Alander Pulliam Unveils "Platform for Transformation" – A Bold Blueprint to Dismantle Oppres
- KeysCaribbean Offers 20 Percent Off Seven-Night Stays For Private Home Collection Properties
- Advancing Circular Economy in Automotive ESD Packaging
- Playwrights Announced For The 2025 Bill And Judy Garrett Finish Line Commission
RefleXion is a privately-held therapeutic oncology company developing the first biology-guided radiotherapy (BgRT) machine, with the potential to move beyond single tumor therapy to one day treat multiple metastatic tumors throughout the body in the same treatment session. Currently, the RefleXion machine is cleared for the delivery of stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT). The company is also developing BgRT, which incorporates positron-emission tomography (PET) data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with sub-second latency.
*The RefleXion X1 BgRT capability requires 510(k) clearance; this feature is not available for sale.
Filed Under: Business
0 Comments
Latest on The Californer
- The Best Cartier Dupe Bracelets to Buy in 2025
- A Milestone of Giving: Ten Percent Group Donates £25,000 to Cure Parkinson's
- Suicide Commando Ignites DNA Lounge in a Night of Industrial Euphoria
- Tami Goveia Enters FabOver40, Inspiring Hollywood Legacy for Breast Cancer Cause
- Trump shutdown could soon halt food support for millions in California; CalFresh cards face possibility of no new funds in November
- Why Authentic Communication Will Outperform AI in the Future of Sales
- California: Governor Newsom to the Supreme Court: do not let Trump use the military against American communities
- Luxury Hospitality Advisors Launches Realtor Training Based on Five Star Hotel Service Training
- Swidget Launches Luminance™ to Help Schools Achieve Alyssa's Law Compliance
- Farther's Michael Lee Named One of InvestmentNews' Rising Stars of 2025
- Growing Demand for EVA Mats Signals Shift in Car Interior Market
- 4th Annual Holidays In The Village, A European Marketplace
- Moorpark College Named 2025 Pathway Champion for Driving Equity in Transfer Success
- MDRN MUSE Expands Insurance Network Coverage to Include Delta Dental & Cigna
- Chera TV: The Female-Led Platform Redefining Hollywood's Next Era of Storytelling
- California Student Aid Commission Launches 2026-27 Statewide Financial Aid Cycle at Ventura College
- California: Governor Newsom supports workers as Trump's shutdown hurts the economy
- California strengthens its pipeline for good-paying jobs, providing $25 million to train more than 22,000 workers through apprenticeship programs
- Why Voting "No on Prop 50" Makes Sense
- Hollywood In Pixels Celebrates the 8th Annual Silver Pixel Awards and Announces 2025 Campaign Pixel Winners Los Angeles, CA — Oct